Date | Time | Source | Headline | Symbol | Company |
27/09/2012 | 20:07 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
27/09/2012 | 17:57 | PR Newswire (US) | Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
27/09/2012 | 16:40 | Dow Jones News | FDA Approves Bayer Colon Cancer Drug | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
27/09/2012 | 16:25 | Dow Jones News | FDA Approves Bayer AG Colon Cancer Drug Stivarga | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
24/09/2012 | 14:28 | Zacks | CHMP Positive on Novartis' Votubia - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
20/09/2012 | 10:00 | Zacks | FDA Panel to Review Celgene Drug - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
17/09/2012 | 17:31 | Zacks | Celsion Progresses with ThermoDox - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
12/09/2012 | 01:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
10/09/2012 | 19:06 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
07/09/2012 | 01:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
07/09/2012 | 01:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/09/2012 | 16:00 | Zacks | EC Approves Pfizer's Inlyta - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/09/2012 | 13:30 | Zacks | Bayer Seeks Regorafenib Approval - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
04/09/2012 | 21:00 | PR Newswire (US) | Onyx Pharmaceuticals To Present At Upcoming Investor Conferences | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/09/2012 | 00:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
30/08/2012 | 15:16 | PR Newswire (US) | Bayer Submits New Drug Application for Regorafenib for the Treatment of Gastrointestinal Stromal Tumors (GIST) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
28/08/2012 | 22:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
27/08/2012 | 14:31 | PR Newswire (US) | Critical Alerts For Amazon.com, Nike, Peabody Energy, Onyx Pharmaceuticals, and Fifth Third Bancorp Released By InvestorsObse... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
18/08/2012 | 01:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/08/2012 | 22:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/08/2012 | 02:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/08/2012 | 02:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/08/2012 | 02:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/08/2012 | 02:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/08/2012 | 02:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
08/08/2012 | 09:15 | Zacks | Onyx Loss up on Wider Costs - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
06/08/2012 | 22:02 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
04/08/2012 | 00:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
04/08/2012 | 00:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/08/2012 | 21:59 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |